Mark Cuban’s company sells 6,000+ medicines to healthcare sites

In less than a year, Mark Cuban’s Cost Plus Marketplace has expanded its portfolio to more than 6,000 medicines. 

Advertisement

Mark Cuban Cost Plus Drug Co. launched the Marketplace in February 2024, which at the time had more than 4,000 medicines in short supply to directly sell to healthcare facilities. 

Since then, customers have realized savings between 40% and 60% compared to traditional wholesalers, according to Chief Commercial Officer Alan Bowe. 

The Marketplace now sells to thousands of hospitals, clinics, ambulatory surgery centers, long-term care sites, dialysis centers and retail pharmacies in all 50 states, Mr. Bowe told Becker’s Jan. 23. 

Tacoma, Wash.-based MultiCare Health System, Louisville, Ky.-based ScionHealth, Franklin, Tenn.-based Community Health Systems and Philadelphia-based Penn Medicine have all begun procuring medications from the Marketplace. Seven months after buying 125 discounted generics, MultiCare saved $1.12 million. 

“Shark Tank” entrepreneur Mark Cuban opened the startup pharmaceutical company in January 2022 with about 100 discounted generics to sell directly to patients. For 2025, Mr. Cuban told Becker’s he plans to publish contracts with healthcare providers and add more brand-name medicines and biosimilars to the company’s portfolio.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.